Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.48 |
| ▸ | ALB | P02768 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | DRD1 | P21728 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1182463 | 0.84 | ALDH1A1 (0.50) | TTRALBMEN1KMT2AHTT | |
| SCHEMBL2670914 | 0.84 | TTR (0.58) | TTRALBMEN1KMT2AHTT | |
| SCHEMBL30464787 | 0.82 | ALDH1A1 (0.48) | TTRALBMEN1KMT2AHTT | |
| SCHEMBL25124119 | 0.78 | TTR (0.52) | TTRALBMEN1KMT2AHTT | |
| SCHEMBL16936198 | 0.78 | TTR (0.52) | TTRALBMEN1KMT2AHTT | |
| SCHEMBL2339085 | 0.78 | ALDH1A1 (0.39) | TTRALBMEN1KMT2AHTT | |
| SCHEMBL11436064 | 0.77 | TTR (0.50) | TTRALBMEN1KMT2AHTT | |
| SCHEMBL11685893 | 0.77 | ALDH1A1 (0.37) | TTRALBMEN1KMT2AHTT | |
| SCHEMBL987538 | 0.76 | MEN1 (0.45) | TTRALBMEN1KMT2AHTT | |
| SCHEMBL1145042 | 0.75 | AR (0.44) | TTRALBHTTCYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9969717-B2 | Method for producing substituted anthranilic acid derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-05-15 | — | — | US | disclosed |
| US-20170217934-A1 | METHOD FOR PRODUCING SUBSTITUTED ANTHRANILIC ACID DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH | 2017-08-03 | — | — | US | disclosed |
| US-9670182-B2 | Method for producing substituted anthranilic acid derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-06-06 | — | — | US | disclosed |
| US-20160046607-A1 | METHOD FOR PRODUCING SUBSTITUTED ANTHRANILIC ACID DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-02-18 | — | — | US | disclosed |
| US-20150011772-A1 | METHOD FOR PRODUCING SUBSTITUTED ANTHRANILIC ACID DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-01-08 | — | — | US | disclosed |
| EP-2812310-A1 | METHOD FOR PRODUCING SUBSTITUTED ANTHRANILIC ACID DERIVATIVES | Bayer Intellectual Property GmbH (DE) | 2014-12-17 | — | — | EP | disclosed |
| WO-2013117601-A1 | METHOD FOR PRODUCING SUBSTITUTED ANTHRANILIC ACID DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-08-15 | — | — | WO | disclosed |
| WO-2010093191-A2 | NOVEL COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | LG LIFE SCIENCES LTD. (KR) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160046607-A1 | METHOD FOR PRODUCING SUBSTITUTED ANTHRANILIC ACID DERIVATIVES | NQO2, PAH, ANTXR2 | TTR 4118/4885ALB 811/4885MEN1 1189/4885 |
| US-20170217934-A1 | METHOD FOR PRODUCING SUBSTITUTED ANTHRANILIC ACID DERIVATIVES | NQO2, PAH, ANTXR2 | TTR 4118/4885ALB 811/4885MEN1 1189/4885 |
| US-20150011772-A1 | METHOD FOR PRODUCING SUBSTITUTED ANTHRANILIC ACID DERIVATIVES | NQO2, PAH, ANTXR2 | TTR 4118/4885ALB 811/4885MEN1 1189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.